Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Monsanto Company (MON), Intrepid Potash, Inc. (IPI): Why You Should Invest in the Leaders of the Agriculture Industry

Page 1 of 2

World population growth is putting an ever increasing stress on food producers. The situation is aggravated by irregular rain patterns and soil degradation. In order to meet the rising demand, since the 1960’s, farmers have turned to genetically modified seeds, pesticides, and nutrients. Hence, Monsanto Company (NYSE:MON)Intrepid Potash, Inc. (NYSE:IPI), and Syngenta AG (ADR) (NYSE:SYTserve a meaningful purpose for the society.

genetically modified foods
Protect investment

Earlier, granddad visited the farm on a daily basis to pull-out weeds by hand. Today, thanks to companies like
Syngenta AG (ADR) (NYSE:SYT), the labor is fairly easy. Nevertheless, lots of R&D and millions of dollars were required. For a company that depends on its R&D to secure revenue, the risks are huge, and so are the rewards if successful.

Take a look at glyphosate’s market introduction and returns. Besides the fact that Syngenta AG (ADR) (NYSE:SYT) trails competitors in the seeds market, the company was able to exploit niches outside genetically modified seeds and introduce innovative crop protection products with relevant market impact, allowing the company to reduce the revenue and market gap with competitors.

Syngenta AG (ADR) (NYSE:SYT) has probably the longest traceable history in the market even though the company was founded in 2000. Hence, its crop protection accumulated know-how is without a doubt the most extensive, reducing Syngenta AG (ADR) (NYSE:SYT)‘s R&D investment risks. For this reason, looking at fundamentals is pointless, because intelligent acquisitions have allowed Syngenta AG (ADR) (NYSE:SYT) to push the technological frontier and reward shareholders in unison. At the same time, Syngenta differentiates itself from direct competitors like Monsanto by diversifying its operations — and risks.

Financially, Syngenta is in a very sound position, even though future estimates are questioned by some analysts. That is, Syngenta is liable to many lawsuits due to environmental and advertising issues. The reader should be wise enough to know that in the agrochemical business, no one is safe from such misfortune. Just like Syngenta takes risks, so do Monsanto Company (NYSE:MON) and Intrepid Potash, Inc. (NYSE:IPI). In the end, what the investor should look at are the prospects and Syngenta has very good ones.

Lastly, planting in the U.S. has been delayed, and so will Syngenta´s revenue this year. This means the investor has more time to make a choice and enjoy positive returns. So, hold is the most responsible recommendation at this point. But, since any investor wants to take advantage of a relative low price that offers good returns in the short and long-term, it is recommended as a buy.

Market leadership

There are two simple reasons for a successful company like Monsanto Company (NYSE:MON) to maintain its leadership: R&D and world population growth. Its new product´s market impact is unquestionable. That impact is aided by world population growth coupled with increasing food demand. Market leadership and growing demand are two catalysts that cannot be ignored when evaluating any company’s prospects.

By the end of the 1990´s, Monsanto Company (NYSE:MON) knew about the potential market effect of roundup-ready soybean and traveled to Argentina in 1998 to test it. Besides testing the new seed on the world´s best farming soil, Monsanto Company (NYSE:MON) looked to shorten R&D evaluations by conducting two tests in one year – given the fact the U.S. and Argentina have different planting seasons.

But, by the end of the second millennium, Henry Wickham’s tale is very-well known and the Argentines took a very good lesson from it: that which has not yet been patented is anyone’s property. In the end, the Argentines kept and exploited the RR soybean with great returns. Surely, in the future, Monsanto Company (NYSE:MON) will pay more attention when testing drought-resistant corn, its new product and the upcoming star of its portfolio.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!